AI assistant
BioPorto Board/Management Information 2019
3424_rns_2019-08-15_5576184a-9023-4b97-81be-51cc412f7966.html
Board/Management Information
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
August 15, 2019
Announcement no. 16
BioPorto A/S - Extraordinary General Meeting
Today, BioPorto A/S held an extraordinary general meeting where Christopher Lindop and Michael Singer were elected as members of the Board of Directors. There were no other changes to the composition of the Board of Directors.
Hellerup, August 15, 2019
BioPorto A/S
The Board of Directors
For further information, please contact:
Peter Mørch Eriksen, CEO
Ole Larsen, CFO
Telephone +45 4529 0000, e-mail [email protected]
About BioPorto
BioPorto is an in-vitro diagnostics company that provides healthcare professionals in clinical and research settings a range of diagnostic tests and antibodies. BioPorto has its headquarters in Hellerup, Denmark and is listed on the NASDAQ Copenhagen stock exchange
Attachment